| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2778 |
Injection, ranibizumab, 0.1 mg |
1,245 |
1,152 |
$1.00M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,212 |
2,878 |
$180K |
| 92134 |
|
3,087 |
2,681 |
$70K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,076 |
1,013 |
$56K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
683 |
635 |
$40K |
| J9035 |
Injection, bevacizumab, 10 mg |
291 |
279 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
243 |
241 |
$17K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
247 |
231 |
$14K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
14 |
14 |
$12K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
102 |
101 |
$11K |
| 92250 |
|
278 |
263 |
$7K |
| J7999 |
Compounded drug, not otherwise classified |
246 |
216 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$3K |
| 92133 |
|
54 |
52 |
$694.23 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
15 |
$563.55 |
| 92015 |
Determination of refractive state |
39 |
37 |
$180.09 |